Skip to main content
Ventripoint Diagnostics Ltd. logo

Ventripoint Diagnostics Ltd. - Investor Relations & Filings

Listed
Ticker · VPT ISIN · CA92281P2008 LEI · 529900QV0P93LL6P2M57 TSXV Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 696 across all filing types
Latest filing 2025-12-03 Board/Management Inform…
Country CA Canada
Listing TSXV VPT · 6 venues

Key figures FY2025

Period ended 2025-12-31 · CAD
Headline annual figures for Ventripoint Diagnostics Ltd., fiscal year 2025, reported in CAD, with the source filing for each figure.
Total Revenues CAD 179.93k per the Annual Report filed 2026-05-01
Net Income CAD -3.20M per the Annual Report filed 2026-05-01
Total Assets CAD 472.08k per the Annual Report filed 2026-05-01
Total Equity CAD -4.12M per the Annual Report filed 2026-05-01
Cash from Ops CAD -1.55M per the Annual Report filed 2026-05-01

As reported by the issuer in the filings linked above. Figures are normalized for comparability; consult the source filing for the authoritative statement.

About Ventripoint Diagnostics Ltd.

https://ventripoint.com/

Ventripoint Diagnostics Ltd. is a medical device company specializing in AI-driven cardiac imaging solutions. The company's patented technology, embodied in the VMS+ software, transforms standard 2D echocardiograms into high-fidelity 3D models of all four heart chambers. This process provides accurate, reproducible volumetric measurements and ejection fractions, offering diagnostic performance comparable to MRI but with the speed and cost-effectiveness of ultrasound. The VMS+ system is designed to aid in monitoring patients with heart conditions, delivering detailed heart analysis even when using imperfect images or on patients who cannot undergo MRI procedures, such as those with pacemakers.

Recent filings

Filing Released Lang Actions
Material change report - English.pdf
Board/Management Information Classification · 95% confidence The document is a 'Material Change Report' (Form 51-102F3) filed in Canada, which is a regulatory requirement to disclose significant corporate events. The core content of this report is the announcement of the appointment of a new Chief Financial Officer (CFO). According to the filing definitions, announcements regarding changes in senior management fall under the 'Board/Management Information' (MANG) category. While it is a regulatory filing, the specific nature of the material change (management appointment) makes MANG the most precise classification.
2025-12-03 English
News release - English.pdf
Board/Management Information Classification · 100% confidence The document is a press release announcing the appointment of a new Chief Financial Officer (David Swetlow) and the resignation of the former CFO (Jimmy Jeon). This falls directly under the category of Board/Management Information, which covers announcements of changes in senior management.
2025-12-03 English
52-109FV2 - Certification of interim filings - CEO (E).pdf
Regulatory Filings Classification · 100% confidence The document is a 'Form 52-109FV2', which is a standard Canadian regulatory form for the certification of interim filings by a CEO. According to the 'Certification Rule', documents that are primarily officer certifications or attestations, even if they reference a specific report type (like an interim report), should be classified as Regulatory Filings (RNS) rather than the report itself. The document contains no financial data, only the CEO's attestation regarding the quality of the filings.
2025-11-28 English
Interim financial statements/report – English.pdf
Interim / Quarterly Report Classification · 100% confidence The document is a 'Condensed Interim Consolidated Financial Statement' for Ventripoint Diagnostics Ltd. for the three and nine months ended September 30, 2025. It contains comprehensive financial statements (Statement of Financial Position, Statement of Loss and Comprehensive Loss, Statement of Cash Flows, and Statement of Changes in Shareholders' Equity) along with detailed notes. It is not an annual report (10-K) nor an earnings release (ER), but rather a formal interim financial report. Therefore, it fits the definition of an Interim/Quarterly Report (IR). 9M 2025
2025-11-28 English
News release - English.pdf
Capital/Financing Update Classification · 95% confidence The document is a news release announcing that Ventripoint Diagnostics Ltd. has entered into debt settlement agreements by issuing common shares to creditors. This constitutes a change in the company's capital structure and financing activities. According to the provided definitions, 'Capital/Financing Update' (CAP) covers updates on company fundraising, financing activities, or capital structure changes. While it involves the issuance of shares, it is specifically framed as a debt settlement, making CAP the most accurate classification.
2025-11-06 English
AGM 2025
Call Transcript Classification · 100% confidence The document is a verbatim transcript of a shareholder update call, featuring a CEO presentation followed by a Q&A session. It includes speaker identification, audience interaction (e.g., 'Could you please mute your phones'), and specific Q&A segments. This aligns perfectly with the definition of a Call Transcript (CT).
2025-10-30 English

Browse filings by year

21 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.